Back

Micro-embolic risks during radiofrequency and cryoballoon-ablation of atrial fibrillation -analysis from real-time carotid artery doppler monitoring-

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Ablation for Atrial Fibrillation around the Globe; Techniques, Technologies and More Mechanisms for Stroke ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Reina Tonegawa-Kuji

National Cerebral & Cardiovascular Center, Suita (Japan)

8 More presentations in this session

Presentation thumbnail
Real life experience with atrial fibrillation cryoballoon ablation: results from a nationwide registry
Doctor T. Lubimceva (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
The safety of catheter ablation of atrial fibrillation in elderly patients -analysis of the nationwide database in Japan, JROAD-DPC-
Doctor Y. Yokoyama (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Trends in complications and mortality following catheter ablation of atrial fibrillation: results from 22,582 ablations in Australia and New Zealand from 2010 to 2015
Doctor L. Ngo (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Patient outcomes after AF ablation using Ablation Index technology with oesophageal protection: insight from the IMPACT study.
Doctor L. Leung (London, GB)
Abstract Slides Video
Presentation thumbnail
The outcome of ablation for non-paroxysmal atrial fibrillation targeting spatiotemporal electrogram dispersion compared with ganglionated plexi ablation
Doctor K. Sakata (Takatsuki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Ablation for Atrial Fibrillation around the Globe; Techniques, Technologies and More

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Treatment strategies for atrial fibrillation in heart failure - discussion
thumbnail
Congress Presentation
We really need long-term cardiac rhythm monitoring after embolic stroke of unknown source - discussion
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources